NEW YORK (GenomeWeb) – Hologic said today that it expects to report total revenues of $653 million for its fiscal first quarter ending Dec. 31, 2014.

The preliminary revenues represent a 7 percent increase over the prior-year period and exceed the company's previous quarterly revenue guidance of $625 million to $635 million. The projected revenues also beat consensus analyst estimates of $631 million for the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.